ECP 2022 Final Programme

Tuesday, 6 Sept 171 ECP 2022 Basel 004 13:54–14:12 Biopsy collection in cholangiocarcinoma: Current status and future perspectives Ana Vivancos, Spain 005 14:12–14:27 Panel discussion and Q&A All 006 14:27–14:30 Closing remarks Aldo Scarpa, Italy ES-03 Industry Symposium 19:30–20:30 Boston Molecular biomarkers in metastatic NSCLC: current and future perspectives (Daiichi Sankyo) Chair: Reinhard Büttner, Germany 001 Welcome and introduction Reinhard Büttner, Germany 002 Molecular testing in metastatic NSCLC: the here and now Reinhard Büttner, Germany 003 Emerging biomarkers for metastatic NSCLC: the next generation Sacha Rothschild, Switzerland 004 Real-world molecular testing: sharing best practice Umberto Malapelle, Italy 005 Audience Q&A and closing remarks Audience and Faculty e Tuesday, 6 September 2022 BRS-04 Industry Symposium 07:15–08:15 Shanghai Comprehensive molecular profiling – speed and simplicity in solid tumor and haemato – malignancies clinical research (Thermo Fisher Scientific) Chair: Michael Hummel, Germany 001 07:15–07:20 Welcome & Introduction Michael Hummel, Germany 002 07:20–07:35 The role of comprehensive genomic profiling in solid tumor biomarker testing Gorka Alkorta-Aranburu, Spain 003 07:35–07:50 NGS molecular profile of paediatric brain tumours: results from 100 consecutive patients treated at Centro Hospitalar Universitário de São João Jorge Lima, Portugal 004 07:50–08:05 The impact of NGS molecular profiling in myeloid malignancies Monica Lopez-Guerra, Spain 005 08:05–08:15 Q&A Michael Hummel, Germany BRS-05 Industry Symposium 07:15–08:15 Osaka/Samarkand From genes to decisions: How to master the increasing data flood in comprehen- sive genomic profiling (Molecular Health) Chair: Marc-Alexander Rauschendorf, Germany 001 Introduction Marc-Alexander Rauschendorf, Germany 002 Charité Comprehensive Cancer Center Molecular Tumorboard: Experience with MH Guide as an annotation tool for large gene panels Claudia Vollbrecht, Germany Industry Symposia Monday, 5 Sept